The clinicopathological predictors of deleterious germline variants in panel-gene, HRR-related gene, and BRCA1/2 were consistent, including younger age at initial diagnosis of BC, positive family history of any cancer, TN phenotype, high expression of Ki-67, and hereditary high risk. The gene discussed is MKI67; the disease is breast cancer.